United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
545.96
+0.56 (0.10%)
At close: Jun 12, 2026, 4:00 PM EDT
547.11
+1.15 (0.21%)
After-hours: Jun 12, 2026, 6:36 PM EDT
United Therapeutics Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, United Therapeutics stock has a consensus rating of "Buy" and an average price target of $665.23. The average 1-year stock price forecast is 21.85% higher than the current stock price, while the lowest is $516 (-5.49%) and the highest is $750 (+37.37%).
Price Target: $665.23 (+21.85%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 5 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $516 | Hold | Maintains | $516 | -5.49% | Jun 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $660 | Buy | Maintains | $660 | +20.89% | May 29, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $685 | Buy | Maintains | $685 | +25.47% | May 20, 2026 |
| Jefferies | Jefferies | Buy Maintains $668 → $733 | Buy | Maintains | $668 → $733 | +34.26% | May 19, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $660 → $675 | Buy | Maintains | $660 → $675 | +23.64% | May 18, 2026 |
Financial Forecast
Revenue This Year
3.26B
from 3.18B
Increased by 2.55%
Revenue Next Year
3.70B
from 3.26B
Increased by 13.35%
EPS This Year
27.17
from 27.86
Decreased by -2.49%
EPS Next Year
31.77
from 27.17
Increased by 16.96%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.4B | ||
| Avg | 3.3B | ||
| Low | 3.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.8% | ||
| Avg | 2.6% | ||
| Low | -1.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 32.68 | ||
| Avg | 27.17 | ||
| Low | 24.93 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.3% | ||
| Avg | -2.5% | ||
| Low | -10.5% |